Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case‐based approach

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-1069|36|1|258-261

ISSN: 0278-0232

Source: Hematological Oncology (Electronic), Vol.36, Iss.1, 2018-02, pp. : 258-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract